Legend Biotech (LEGN) Asset Utilization Ratio (2020 - 2025)

Legend Biotech has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.6 in Q4 2025.

• For the quarter ending Q4 2025, Asset Utilization Ratio rose 62.08% year-over-year to 0.6; the trailing twelve-month figure through Dec 2025 stood at 0.6 (up 62.08% YoY), and the FY2025 full-year result was 0.6, up 69.56% from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.6, up from 0.53 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 45.22 in Q3 2024, with the low at 0.0 in Q2 2021.
• Historically, Asset Utilization Ratio has averaged 10.59 across 5 years, with a median of 0.37 in 2024.
• The largest YoY upside for Asset Utilization Ratio was 54004.99% in 2024 against a maximum downside of 99.15% in 2024.
• Legend Biotech's Asset Utilization Ratio stood at 0.09 in 2021, then advanced by 25.53% to 0.12 in 2022, then jumped by 36951.55% to 43.21 in 2023, then tumbled by 99.15% to 0.37 in 2024, then soared by 62.08% to 0.6 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.6 (Q4 2025), 0.53 (Q3 2025), and 0.48 (Q2 2025), per Business Quant data.